Agilent Technologies, Inc. (NYSE:A) Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 67.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,288 shares of the medical research company's stock after selling 12,787 shares during the quarter. TD Private Client Wealth LLC's holdings in Agilent Technologies were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of A. CKW Financial Group grew its stake in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. lifted its position in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $29,000. RPg Family Wealth Advisory LLC purchased a new position in Agilent Technologies in the third quarter valued at approximately $38,000. Finally, Hanson & Doremus Investment Management grew its position in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after buying an additional 105 shares during the last quarter.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded down $0.86 during trading on Thursday, hitting $119.04. 2,075,716 shares of the company were exchanged, compared to its average volume of 1,684,361. The firm has a 50 day moving average price of $135.43 and a 200 day moving average price of $136.92. The stock has a market capitalization of $33.94 billion, a price-to-earnings ratio of 27.37, a P/E/G ratio of 3.38 and a beta of 1.11. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a fifty-two week low of $117.17 and a fifty-two week high of $155.35.

Remove Ads

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.83%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Barclays raised Agilent Technologies from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $135.00 to $145.00 in a report on Monday, February 10th. Bank of America dropped their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research note on Friday, December 13th. Wells Fargo & Company reduced their target price on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a report on Monday, December 9th. Citigroup boosted their price objective on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a report on Thursday, December 19th. Finally, StockNews.com raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and an average price target of $150.83.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The disclosure for this sale can be found here.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.